Citation

Todder D, Baune BT. J. Med. Case Reports 2007; 1(1): 166.

Copyright

(Copyright © 2007, Holtzbrinck Springer Nature Publishing Group - BMC)

DOI

10.1186/1752-1947-1-166

PMID

18053177

PMCID

PMC2170450

Abstract

This report describes a patient suffering from panic disorder who developed repeated suicidal ideation specifically due to the treatment with Venlafaxine. A first suicide attempt years ago occurred while being treated with Venlafaxine. Subsequent treatment with SSRIs or other antidepressants involved no suicidal ideation. Re-commencement of Venlafaxine four years later immediately led to a second suicide attempt. This unwanted effect subsided immediately after switching to another SNRI (i.e. Duloxetine). The case report underlines the importance of onset of suicide risk in panic disorders due to specific antidepressants.

Language: en